199 related articles for article (PubMed ID: 19026659)
21. Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity.
Huarte N; Araujo A; Arranz R; Lorizate M; Quendler H; Kunert R; Valpuesta JM; Nieva JL
PLoS One; 2012; 7(12):e52740. PubMed ID: 23285173
[TBL] [Abstract][Full Text] [Related]
22. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
23. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade.
Huang J; Dong X; Liu Z; Qin L; Chen YH
Immunol Lett; 2002 Dec; 84(3):205-9. PubMed ID: 12413738
[TBL] [Abstract][Full Text] [Related]
24. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
[TBL] [Abstract][Full Text] [Related]
25. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
Wahome N; Pfeiffer T; Ambiel I; Yang Y; Keppler OT; Bosch V; Burkhard P
Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
[TBL] [Abstract][Full Text] [Related]
26. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.
Huarte N; Lorizate M; Maeso R; Kunert R; Arranz R; Valpuesta JM; Nieva JL
J Virol; 2008 Sep; 82(18):8986-96. PubMed ID: 18596094
[TBL] [Abstract][Full Text] [Related]
27. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
Venditto VJ; Wieczorek L; Molnar S; Teque F; Landucci G; Watson DS; Forthal D; Polonis VR; Levy JA; Szoka FC
Clin Vaccine Immunol; 2014 Aug; 21(8):1086-93. PubMed ID: 24872518
[TBL] [Abstract][Full Text] [Related]
28. Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.
Venditto VJ; Watson DS; Motion M; Montefiori D; Szoka FC
Clin Vaccine Immunol; 2013 Jan; 20(1):39-45. PubMed ID: 23114698
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
Menendez A; Chow KC; Pan OC; Scott JK
J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434
[TBL] [Abstract][Full Text] [Related]
30. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
Shen X; Dennison SM; Liu P; Gao F; Jaeger F; Montefiori DC; Verkoczy L; Haynes BF; Alam SM; Tomaras GD
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5972-7. PubMed ID: 20231447
[TBL] [Abstract][Full Text] [Related]
31. The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER.
Apellániz B; Nieva JL
Adv Protein Chem Struct Biol; 2015; 99():15-54. PubMed ID: 26067815
[TBL] [Abstract][Full Text] [Related]
32. Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
Yi G; Lapelosa M; Bradley R; Mariano TM; Dietz DE; Hughes S; Wrin T; Petropoulos C; Gallicchio E; Levy RM; Arnold E; Arnold GF
PLoS One; 2013; 8(9):e72205. PubMed ID: 24039745
[TBL] [Abstract][Full Text] [Related]
33. Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.
Parker CE; Deterding LJ; Hager-Braun C; Binley JM; Schülke N; Katinger H; Moore JP; Tomer KB
J Virol; 2001 Nov; 75(22):10906-11. PubMed ID: 11602730
[TBL] [Abstract][Full Text] [Related]
34. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies.
Yang G; Holl TM; Liu Y; Li Y; Lu X; Nicely NI; Kepler TB; Alam SM; Liao HX; Cain DW; Spicer L; VandeBerg JL; Haynes BF; Kelsoe G
J Exp Med; 2013 Feb; 210(2):241-56. PubMed ID: 23359068
[TBL] [Abstract][Full Text] [Related]
35. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.
Dennison SM; Stewart SM; Stempel KC; Liao HX; Haynes BF; Alam SM
J Virol; 2009 Oct; 83(19):10211-23. PubMed ID: 19640992
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
[TBL] [Abstract][Full Text] [Related]
37. Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.
Strasz N; Morozov VA; Kreutzberger J; Keller M; Eschricht M; Denner J
AIDS Res Hum Retroviruses; 2014 May; 30(5):498-508. PubMed ID: 24392780
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design.
Joyce JG; Hurni WM; Bogusky MJ; Garsky VM; Liang X; Citron MP; Danzeisen RC; Miller MD; Shiver JW; Keller PM
J Biol Chem; 2002 Nov; 277(48):45811-20. PubMed ID: 12237296
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
40. Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion.
Barbato G; Bianchi E; Ingallinella P; Hurni WH; Miller MD; Ciliberto G; Cortese R; Bazzo R; Shiver JW; Pessi A
J Mol Biol; 2003 Jul; 330(5):1101-15. PubMed ID: 12860131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
